Science
Mechanism of Action
It functions via a multi-pathway anti-inflammatory approach, suppressing key mediators like TNF-α and IL-6 while inhibiting the NF-κB pathway. Active compounds chamazulene and bisabolol target surface redness, while the flavonoid apigenin boosts the production of essential barrier proteins like filaggrin and loricrin.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Demonstrated efficacy comparable to 0.25% hydrocortisone in treating eczematous symptoms.
- 02 A 2% concentration significantly accelerated wound healing and reduced inflammatory markers in skin damage models.
- 03 Safety testing at 2.5% confirmed high tolerability, with adverse reactions occurring in less than 1% of the test population.
Transparency
Dusting Analysis
While frequently listed on labels for its marketing appeal, Chamomilla Recutita requires a concentration of at least 1-2% to deliver therapeutic anti-inflammatory results. Formulations listing it near the bottom of the INCI (below 0.1%) are likely 'dusting' the ingredient for claim purposes only.
The Formula
Formulation
Stability
Highly sensitive to alkaline environments (pH > 8) and high thermal processing. Volatile components like chamazulene degrade if exposed to temperatures exceeding 40°C.
Synergies
- Hyaluronic Acid
- Glycerin
- Panthenol
Conflicts
- Strong oxidizers
- Highly alkaline surfactants
Safety
Safety Profile
Individuals with known allergies to the Asteraceae/Compositae (daisy) family should perform a patch test. CIR notes highest leave-on use at 0.5% for makeup and 1.0% for rinse-off.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance botanical essential for any regimen targeting inflammation, redness, or barrier compromise.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources